- Report
- July 2022
- 100 Pages
Global
From €2614EUR$2,750USD£2,196GBP
- Report
- August 2022
- 117 Pages
Global
From €4278EUR$4,500USD£3,594GBP
- Report
- July 2022
- 131 Pages
Global
From €4278EUR$4,500USD£3,594GBP
- Report
- June 2023
- 159 Pages
Global
From €7130EUR$7,500USD£5,990GBP
- Report
- January 2022
- 200 Pages
Global
From €7130EUR$7,500USD£5,990GBP
- Report
- January 2022
- 200 Pages
Global
From €7130EUR$7,500USD£5,990GBP
- Report
- January 2022
- 60 Pages
Global
From €3755EUR$3,950USD£3,155GBP
- Report
- April 2023
- 147 Pages
Global
From €4705EUR$4,949USD£3,952GBP
- Report
- March 2023
- 147 Pages
Global
From €4705EUR$4,949USD£3,952GBP
- Report
- May 2023
- 160 Pages
Global
From €4705EUR$4,949USD£3,952GBP
- Report
- November 2023
- 171 Pages
Global
From €2377EUR$2,500USD£1,997GBP
- Report
- January 2022
- 120 Pages
Global
From €2377EUR$2,500USD£1,997GBP
- Report
- August 2022
Global
From €751EUR$790USD£631GBP
- Report
- August 2022
United States
From €1844EUR$1,940USD£1,549GBP
- Report
- August 2022
Global
From €751EUR$790USD£631GBP
- Report
- August 2021
Europe
From €3251EUR$3,420USD£2,731GBP
- Report
- August 2021
Global
From €3793EUR$3,990USD£3,187GBP
- Drug Pipelines
- March 2021
Global
From €1901EUR$2,000USD£1,597GBP
- Report
- December 2023
- 182 Pages
Global
€4749EUR$4,995USD£3,989GBP
- Report
- August 2024
- 90 Pages
Global
From €3500EUR$3,944USD£3,043GBP

The Neuropathy Drug market is a subset of the Central Nervous System Drugs market, which includes drugs used to treat diseases and disorders of the brain, spinal cord, and peripheral nervous system. Neuropathy drugs are used to treat a variety of conditions, including diabetic neuropathy, postherpetic neuralgia, and chemotherapy-induced peripheral neuropathy. These drugs are typically administered orally, intravenously, or topically, and may include anticonvulsants, antidepressants, and opioids.
The Neuropathy Drug market is highly competitive, with a variety of companies offering products to treat a range of conditions. Some of the major players in the market include Pfizer, GlaxoSmithKline, Novartis, Merck, and Johnson & Johnson. Other companies, such as Eli Lilly, Sanofi, and AstraZeneca, also offer products in this market. Show Less Read more